|
Volumn 2, Issue 10, 2004, Pages 865-867
|
The wizards of odds: Cost-effectiveness, Barrett's screening, and surveillance guidelines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BARRETT ESOPHAGUS;
CANCER DIAGNOSIS;
CANCER EPIDEMIOLOGY;
CANCER SCREENING;
CANCER SUSCEPTIBILITY;
COST EFFECTIVENESS ANALYSIS;
COST UTILITY ANALYSIS;
DISEASE COURSE;
EDITORIAL;
ENDOSCOPY;
ESOPHAGUS BIOPSY;
ESOPHAGUS CARCINOMA;
ESOPHAGUS RESECTION;
HISTOLOGY;
HUMAN;
PUBLIC HEALTH SERVICE;
QUALITY ADJUSTED LIFE YEAR;
TUMOR BIOPSY;
ADENOCARCINOMA;
BARRETT ESOPHAGUS;
COST-BENEFIT ANALYSIS;
ESOPHAGEAL NEOPLASMS;
ESOPHAGOSCOPY;
GASTROESOPHAGEAL REFLUX;
HUMANS;
MASS SCREENING;
POPULATION SURVEILLANCE;
PRECANCEROUS CONDITIONS;
QUALITY-ADJUSTED LIFE YEARS;
UNITED STATES;
|
EID: 5044237701
PISSN: 15423565
EISSN: None
Source Type: Journal
DOI: 10.1016/S1542-3565(04)00395-7 Document Type: Editorial |
Times cited : (4)
|
References (8)
|